EPTIS
BAM Logo

POCT Haemoglobin

[POCT Haemoglobin]

EPTIS Ringversuch Nr. 142674 | Letze Änderung 2024-05-22 | URL: https://www.eptis.bam.de/pts142674 https://www.eptis.bam.de/pts142674

Name des Anbieters
Name des Anbieters Weqas Weqas
Ansässig in United Kingdom
Sprache(n)
Anmerkungen Haemoglobin (Hb) is the iron containing oxygen transport metalloprotein in red blood cells and is one of the most common laboratory tests performed. The test is used to detect and measure the severity of anaemia, monitor the response to treatment, and help make decisions about blood transfusions. Iron deficiency Anaemia is defined as a Hb < 130 g/L in men aged over 15 years, and <120 g/L in non-pregnant women aged over 15 years or children aged 12–14 years, and < 110 g/L during pregnancy. An Hb level of 110 g/L or more appears adequate in the first trimester, and a level of 105 g/L appears adequate in the second and third trimesters. Postpartum a Hb < 100 g/L is consistent with anaemia. POCT Hb is usually undertaken when a fast turnaround time is needed for immediate therapeutic decisions and are often used in the identification and management of anaemia in the perioperative pathway. POCT Hb can be measured on a blood gas analyser (BGA), and on specific POCT devices. The material is purified stroma free bovine haemolysate, requiring no prior preparation. Two samples are distributed bimonthly, with a minimum of 12 samples distributed over the year covering a wide, clinically relevant range. The samples consist of a panel of 5 samples distributed on a number of occasions over that period, which are used to assess both the user and device performance, including linearity, bias, within and between batch imprecision. Key Features: - Ready to use samples in dropper bottles, no need for reconstitution. - Panel of samples distributed covering the pathological range. - Programme assesses both user and device performance, including linearity, bias, within and between batch imprecision. - Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/poct-eqa/poct-haemoglobin/ or contact@weqas.com
Klassifizierung
Produktgruppen Health care / medical devices
Prüfgebiete Medical analysis
Technische Einzelheiten
Prüfobjekt Prüfeigenschaft Prüfmethode
Purified bovine haemolysate Haemoglobin Routine testing methods (recommended)
Ringversuchsziele
Zielgruppe des Ringversuchs The POCT Hb EQA Programme is specifically designed for the quantitative assay of Hb using a POCT Hb device, for Hb measurement using a BGA please refer to our Blood Gas/Co-oximetry EQA Programme.
Relevante Rechtsvorschriften oder Normen Accreditation by UKAS on the basis of ISO/IEC 17025, 17043 and 15195
Weitere Ziele validation of testing methods
Teilnehmerzahl
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt)

Akkreditiert durch UKAS auf der Grundlage von ISO/ IEC 17043

Die Durchführung des Ringversuchs ist in Auftrag gegeben durch
Kosten
Teilnahmegebühr https://www.weqas.com/participantzone/subscription-charges/
Regelmässig durchgeführt Ja (Frequency: Bimonthly. Samples: 2 x 1.0mL. )
Der Ringversuch wird durchgeführt seit 2007
Kontaktdaten des Anbieters
Anbieter Kontaktperson
Weqas
Unit 6, Parc Ty Glas
CF14 5DU Cardiff
United Kingdom

Telefon: 44 (0) 2920 314750
Fax:
Web: http://www.weqas.com http://www.weqas.com
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884
Fax:
E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Haben Sie Fragen? Senden Sie uns eine E-Mail: eptis@bam.de.
Anwendungsversion: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5